Supplemental material, sj-docx-1-cjk-10.1177_20543581231165708 for Health Services Use and Outcomes for Hospital Admissions With a Major Cardiovascular Event Recorded in Health Care Administrative Data in Patients Receiving Maintenance Hemodialysis: A Retrospective Cohort Study by Ahmed A. Al-Jaishi, Nivethika Jeyakumar, Yuguang Kang, Sonali De Chickera, Stephanie N. Dixon, Bin Luo, Jessica Sontrop, Michael Walsh, Marcello Tonelli and Amit X. Garg in Canadian Journal of Kidney Health and Disease

Additional file 1: Table S1. Research Strategy. Table S2. Cochrane Collaboration risk of bias tool for RCT. Table S3. CLARITY for Cohort studies. Table S4. Quality of Evidence. Table S5. Functional recovery at individual timeframe. Table S6. Psychometric questionnaires. Table S7. ROM at individual timeframe.

Additional file 1: Table S1. Research Strategy. Table S2. Cochrane Collaboration risk of bias tool for RCT. Table S3. CLARITY for Cohort studies. Table S4. Quality of Evidence. Table S5. Functional recovery at individual timeframe. Table S6. Psychometric questionnaires. Table S7. ROM at individual timeframe.

Supplemental material, sj-docx-1-cjk-10.1177_20543581231158067 for Long-Term Outcomes for Living Kidney Donors With Early Guideline-Concordant Follow-up Care: A Retrospective Cohort Study by Anisha Dhalla, Anita Lloyd, Krista L. Lentine, Amit X. Garg, Robert R. Quinn, Pietro Ravani, Scott W. Klarenbach, Brenda R. Hemmelgarn, Uchenna Ibelo and Ngan N. Lam in Canadian Journal of Kidney Health and Disease

There is controversy on whether to use incremental monetary net benefit (INMB) or incremental cost-effectiveness ratio (ICER) in health economic evaluations alongside randomized controlled trials. We studied the impact of restricted mean survival time (RMST) on the long-term projection of INMB and ICER. We analyzed the unbiasedness and efficiency of ICER and INMB by (1) deriving the metrics' expected values and variances based on theoretical probability distributions, (2) simulating their 15-year post-trial projections based on...

Supplemental material, sj-pdf-1-cjk-10.1177_20543581221131201 for Enhance Access to Kidney Transplantation and Living Kidney Donation (EnAKT LKD): Statistical Analysis Plan of a Registry-Based, Cluster-Randomized Clinical Trial by Stephanie N. Dixon, Kyla L. Naylor, Seychelle Yohanna, Susan McKenzie, Dmitri Belenko, Peter G Blake, Candice Coghlan, Rebecca Cooper, Lori Elliott, Leah Getchell, Vincent Ki, Istvan Mucsi, Gihad Nesrallah, Rachel E. Patzer, Justin Presseau, Marian Reich, Jessica M. Sontrop, Darin Treleaven, Amy D. Waterman, Jeffrey Zaltzman and Amit X. Garg...

Supplemental material, sj-docx-1-cjk-10.1177_20543581221129442 for The Living Kidney Donor Safety Study: Protocol of a Prospective Cohort Study by Amit X. Garg, Jennifer B. Arnold, Meaghan Cuerden, Christine Dipchand, Liane S. Feldman, John S. Gill, Martin Karpinski, Scott Klarenbach, Greg A. Knoll, Charmaine Lok, Matthew Miller, Mauricio Monroy-Cuadros, Christopher Nguan, G. V. Ramesh Prasad, Jessica M. Sontrop, Leroy Storsley and Neil Boudville in Canadian Journal of Kidney Health and Disease

Additional file 2. Additional details for the external dataset.

Additional file 4: Description of the gamma and c parameters. Fig. S2. This figure shows the decision boundaries and support vectors for different settings of the regularization parameter (C) and Kernel coefficient (gamma). We used the mglearn package to create this figure [27].

Supplemental material, sj-docx-1-wso-10.1177_17474930231168517 for The credibility of subgroup analyses reported in stroke trials is low: A systematic review by Ayoola Ademola, Lehana Thabane, Joel Adekanye, Ayooluwanimi Okikiolu, Samuel Babatunde, Mohammed A Almekhlafi, Bijoy K Menon, Michael D Hill, Kevin A Hildebrand and Tolulope T Sajobi in International Journal of Stroke

Additional file 3. TIDier Checklist.

Additional file 3. TIDier Checklist.

There is controversy on whether to use incremental monetary net benefit (INMB) or incremental cost-effectiveness ratio (ICER) in health economic evaluations alongside randomized controlled trials. We studied the impact of restricted mean survival time (RMST) on the long-term projection of INMB and ICER. We analyzed the unbiasedness and efficiency of ICER and INMB by (1) deriving the metrics' expected values and variances based on theoretical probability distributions, (2) simulating their 15-year post-trial projections based on...

Supplemental material, sj-docx-2-cjk-10.1177_20543581221129442 for The Living Kidney Donor Safety Study: Protocol of a Prospective Cohort Study by Amit X. Garg, Jennifer B. Arnold, Meaghan Cuerden, Christine Dipchand, Liane S. Feldman, John S. Gill, Martin Karpinski, Scott Klarenbach, Greg A. Knoll, Charmaine Lok, Matthew Miller, Mauricio Monroy-Cuadros, Christopher Nguan, G. V. Ramesh Prasad, Jessica M. Sontrop, Leroy Storsley and Neil Boudville in Canadian Journal of Kidney Health and Disease

Additional file 10. Examples of titles and abstracts that were classified incorrectly by our algortihms.

Additional file 1. Justification for using a CRT search filter.

Additional file 5. Continuous skip-gram architecture.

Additional file 9. Details and results for applying our model on a dialysis-related dataset. Table S1. Number of relevant articles retrieved with and without machine learning algorithm using the demonstration dataset (n=882 records). The research objective was to review CRTs in the hemodialysis setting to report key methodological and ethical issues.

Supplemental material, sj-docx-1-ctj-10.1177_17407745221149222 for A hybrid automated event adjudication system for clinical trials by Fei Yuan, Jackie Bosch, John Eikelboom, Gilles R Dagenais, Stuart Connolly, Jane Belanger, Tamara Marsden, Cissy Tang, Balakumar Swaminathan, Martin Renters, Leanne Dyal and Shrikant I Bangdiwala in Clinical Trials

Supplemental material, sj-docx-1-cjk-10.1177_20543581221150676 for Development and Validation of Patient Education Tools for Deprescribing in Patients on Hemodialysis by Thomas Hyunwoo Cho, Patrick C. K. Ng, Melissa J. Lefebvre, Arlene Desjarlais, Dennis McCann, Blair Waldvogel, Marcello Tonelli, Amit X. Garg, JoAnne Wilson, Monica Beaulieu, Judith Marin, Cali Orsulak, Melanie Talson, Monica Sharma, Jordanne Feldberg, Clara Bohm and Marisa Battistella in Canadian Journal of Kidney Health and Disease

Supplemental material, sj-docx-3-psg-10.1177_22925503231161066 for Randomized Controlled Trial Comparing the Clinical Effectiveness of Collagenase Injection (Xiaflex®) and Palmar Fasciectomy in the Management of Dupuytren's Contracture by Achilles Thoma, Jessica Murphy and Lucas Gallo, Bimpe Ayeni, Lehana Thabane in Plastic Surgery

Additional file 1: Table S1. Search strategy for EMBASE and MEDLINE. Table S2. The journals searched for dental speciality.

Supplemental material, sj-docx-1-cjk-10.1177_20543581231165708 for Health Services Use and Outcomes for Hospital Admissions With a Major Cardiovascular Event Recorded in Health Care Administrative Data in Patients Receiving Maintenance Hemodialysis: A Retrospective Cohort Study by Ahmed A. Al-Jaishi, Nivethika Jeyakumar, Yuguang Kang, Sonali De Chickera, Stephanie N. Dixon, Bin Luo, Jessica Sontrop, Michael Walsh, Marcello Tonelli and Amit X. Garg in Canadian Journal of Kidney Health and Disease

Supplemental material, sj-docx-2-cjk-10.1177_20543581221150676 for Development and Validation of Patient Education Tools for Deprescribing in Patients on Hemodialysis by Thomas Hyunwoo Cho, Patrick C. K. Ng, Melissa J. Lefebvre, Arlene Desjarlais, Dennis McCann, Blair Waldvogel, Marcello Tonelli, Amit X. Garg, JoAnne Wilson, Monica Beaulieu, Judith Marin, Cali Orsulak, Melanie Talson, Monica Sharma, Jordanne Feldberg, Clara Bohm and Marisa Battistella in Canadian Journal of Kidney Health and Disease

Supplemental material, sj-docx-1-ctj-10.1177_17407745221149222 for A hybrid automated event adjudication system for clinical trials by Fei Yuan, Jackie Bosch, John Eikelboom, Gilles R Dagenais, Stuart Connolly, Jane Belanger, Tamara Marsden, Cissy Tang, Balakumar Swaminathan, Martin Renters, Leanne Dyal and Shrikant I Bangdiwala in Clinical Trials